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ABSTRACT
The exact mechanism underlying increases in Sp1
and the physiological consequences thereafter
remains unknown. In rat primary cortical neurons,
oxygen-glucose deprivation (OGD) causes an incr-
ease in H2O2 as well as Sp1 in early ischaemia but
apparently does not change mRNA level or Sp1 sta-
bility. We hereby identified a longer 50-UTR in Sp1
mRNA that contains an internal ribosome entry site
(IRES) that regulates rapid and efficient transla-
tion of existing mRNAs. By using polysomal frag-
mentation and bicistronic luciferase assays, we
found that H2O2 activates IRES-dependent transla-
tion. Thus, H2O2 or tempol, a superoxide dismutase-
mimetic, increases Sp1 levels in OGD-treated
neurons. Further, early-expressed Sp1 binds to
Sp1 promoter to cause a late rise in Sp1 in a feed-
forward manner. Short hairpin RNA against Sp1
exacerbates OGD-induced apoptosis in primary
neurons. While Sp1 levels increase in the cortex in
a rat model of stroke, inhibition of Sp1 binding leads
to enhanced apoptosis and cortical injury. These
results demonstrate that neurons can use H2O2 as
a signalling molecule to quickly induce Sp1 transla-
tion through an IRES-dependent translation pathway
that, in cooperation with a late rise in Sp1 via
feed-forward transcriptional activation, protects
neurons against ischaemic damage.
INTRODUCTION
Translation occurs through two mechanisms: a cap-
dependent pathway and a cap-independent pathway that
entails activation of an internal ribosome entry site (IRES)
motif in the 50-UTR region of mRNA (1). Under normal
conditions, nearly all of mammalian genes are translated
into proteins through the cap-dependent pathway.
However, sub-environments including pathogenic infec-
tions, heat shock and hypoxia can induce cells to rapidly
produce sufﬁcient amounts of proteins through the
cap-independent pathway (2–4), activating the IRES to
cope with the environment.
Sp1 is a member of an extended family of the
DNA-binding proteins that have three zinc-ﬁnger motifs
that bind guanosine- and cytosine-rich DNA (5–8). This
family includes members homologous to Sp1 such as Sp2–
Sp4. Sp1 has been implicated in regulating expression of
many genes by acting in concert with other factors,
including members of the TBP-associated factors family
(9), cAMP response element-binding (10,11), nuclear
factor-kB (12) and vascular endothelial growth factor
receptor-2 (VEGFR-2) (13,14). Sp1 is activated during
oxidative stress (15,16) and hypoxia (17,18). However,
both pro-survival (19) and pro-death (20) genes are
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positively correlates with the CD39 expression that
enhances myocardical cell survival (19). However, Sp1
has been speculated to reside in the promoter of
the SUR1-regulated NC (Ca-ATP) channel (21) that
enhances brain oedema. A recent study also revealed
that neuronal injury-inducible genes are synergistically
regulated by ATF3, c-Jun and STAT3 through interaction
with Sp1 in damaged neurons (20). The exact mechanism
underlying the activation or up-regulation of Sp1 during
ischaemia, however, remains an open question. Further,
whether Sp1 is directly involved in the neuroprotection
against hypoxic or middle cerebral artery occlusion
(MCAO)/reperfusion insult has not been determined.
Ischaemic insults typically increase the levels of reactive
oxygen species (ROS); H2O2 is an early-rising ROS and
perhaps has the longest half-life of all ROS. Recent studies
suggest, however, that the generation of mitochondrial
ROS, especially H2O2, is important for neuroprotection
(22,23). In neurons, the hypoxic pre-conditioning protect-
ing against hypoxia seen in the GP 1 transgenic murine
brain has been speculated to involve H2O2 (24). In
addition, H2O2, but not superoxides, protects mature pri-
mary cortical neurons against oxygen-glucose deprivation
(OGD) insult (25). Studies have also shown that H2O2
induces HIF-1a through the NF-kB pathway to protect
neuronal cells (26). Thus, H2O2 and the Sp1 are implicated
in neuronal survival. However, whether and how H2O2 is
related to Sp1 remains unknown.
In this study, using primary cortical neurons and the
MCAO stroke model in rats, we obtained several novel
ﬁndings that directly address several important issues.
These ﬁndings are: (i) the 50-UTR of Sp1 mRNA
contains an IRES motif; (ii) the IRES pathway is activated
by H2O2; and (iii) Sp1 acts as an endogenous protector
against early ischaemic insult.
MATERIALS AND METHODS
Experimental animals and surgical preparation
Male Sprague-Dawley rats weighing 280–320g were used.
They were housed in group cages of two or three rats each
in an air-conditioned vivarium with free access to food
and water. Throughout the study, a 12:12-h light/dark
cycle was maintained with the lights cycle on at 8 AM.
All procedures adhered to the Guidelines for Care and
Use of Experimental Animals of the National Cheng-
Kung University (Tainan, Taiwan). For surgical prepar-
ation, rats (280–320g) were anaesthetized (i.p.) with 10%
chloral hydrate. A 23-gauge stainless steel guide cannula
was then stereotaxically implanted into the piriform cortex
2mm dorsal to the left-middle cerebral artery (MCA). The
stereotaxic coordinates were modiﬁed for this rat strain
(0.2mm anterior,  5.2mm lateral and  8mm ventral
from the bregma) (27,28). Another 23-gauge stainless
steel guide cannula used for intracerebroventricular ad-
ministration of 2ME2 was stereotaxically implanted into
the lateral ventricle (LV;0.4mm posterior,  1.3mmlateral
and  3.5mm ventral, according to a stereotaxic atlas).
The cannula was secured with dental cement and two
small screws were inserted into the skull. Animals were
housed individually, allowed to recover for 3 days, and
divided into drug and vehicle groups before stroke induc-
tion. Rats were divided into drug or vehicle groups before
induction of stroke. Occlusion of the left MCA was in-
duced in conscious rats by administration of endothelin-1
(ET-1, 240pmol in 10ml of saline over 5min) via a
30-gauge injector that protruded 2mm beyond the end
of the previously implanted guide cannula. The injector
was held in place by a poly-tubing cuff and the animal
was placed in a clear Plexiglas box for observation
during the ET-1 injection. To determine whether the
MCA was successfully occluded, regional cerebral blood
ﬂow was measured in the cortex supplied by the MCA by
continuous laser-Doppler ﬂowmetry (Moor Instruments,
Devon, England). At 1day before stroke induction, a
small hole (2mm posterior and 3.5mm lateral to the
bregma) was drilled and a cannula was ﬁxed to the skull
with dental cement. A laser-Doppler ﬂowmetry probe
(0.5mm in diameter) was placed on the dura using the
cannula and cortical-regional cerebral blood ﬂow was
assessed during the entire surgery to ensure MCA occlu-
sion. Only animals with a regional cerebral blood ﬂow
reduction of >75% were included (n=50). It has been
reported that the alteration of cerebral blood ﬂow after
ET-1 injection could be recovered within 1h (29).
Sham-operated rats were subjected to the same surgical
procedure without MCA occlusion.
Culture of cortical neurons and mixed glial cells
Rat cortical neurons were cultured from post-natal Day 0
(P0) to P1. The cortex was dissected and digested in 7ml
of trypsin (10U/ml) in phosphate-buffered saline at 37 C
for 30min. After rinsing, the tissue was triturated and
ﬁltered through a nylon mesh ﬁlter (70mm; Small Parts,
Florida, MI, USA). Cells were plated at a density of
0.5 10
6 cells/cm
2 onto a plastic culture plate that was
pre-coated with poly-L-lysine (50mg/ml, Sigma, St Louis,
MO, USA) and maintained in Neurobasal-A medium sup-
plemented with 100U/ml penicillin, 0.1mg/ml strepto-
mycin, 0.5mM L-glutamine and 5% fetal borine serum
(FBS; Invitrogen, Carlsbad, CA, USA). On the next
day, 8mM cytosine arabinoside (Ara-C; Invitrogen) was
added to prevent glial cell growth. The proportion of
glial cell was <5% in the total population of primary
cortical cultured cells. For primary mixed glial cell culture,
cells were plated at 2 10
5 cells/cm
2 onto a plastic culture
plate coated with poly-L-lysine. Cultures including the
U87 glioma cells and A549 lung cancer cells were main-
tained in Dulbecco’s modiﬁed Eagle’s medium supple-
mented with 5% FBS and 100U/ml penicillin. All of the
cells were kept at 37 C in a humidiﬁed atmosphere of 5%
CO2 and 95% air.
Oxygen-glucose deprivation
In the OGD experiment, primary cortical neurons were
transferred into serum-free medium containing 5mM
2-deoxy-D-glucose (Merck, Darmstadt, Germany) for
1h. The cells were then placed in an anaerobic chamber
that was ﬂushed with a mixture of 95% N2 and 5% CO2.
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aerobic chamber to normal conditions. Having deter-
mined that 60-min OGD caused 40% of the neurons
to become terminal deoxyuridine-triphosphate nick-end
labelling (TUNEL)-positive by 24h, this duration was
used for all further experiments, except when the
time-course experiments were conducted.
ROS measurements
Hydrogen peroxide levels in the extracellular medium were
measured using a Peroxidetect kit (Sigma). Cultured
cortical neurons (0.5 10
6cells/cm
2) were treated as
described in ﬁgure legends. After treatment, 40ml of the
supernatant was analyzed for H2O2 production according
to the manufacturer’s protocol. The absorbance of the
samples was obtained at 560nm and corrected for the ab-
sorbance of vehicle. The concentration of peroxides in
each of the samples was determined and normalized and
expressed as nmol/ml.
RNase protection assays
Brieﬂy, equal amounts of cell lysates were incubated with
or without RNase A (10mg/ml) at 0 C and were then
mixed with 600ml of TRI reagent (Invitrogen, Carlsbad,
CA, USA) to extract cellular mRNA. Reverse transcrip-
tion and real-time polymerase chain reaction (RT–PCR)
was performed as described. Primers for the detection
of Sp1 50-UTR were 50-CTGCAAGGGTCTGATTCT
CTA-30and 50-AGCTTGTCCACCTTGAACTA-30. The
thermal proﬁle used was initiated at 95 C for 2min (pre-
ampliﬁcation hot start), followed by 40 cycles of PCR at
95 C for 10s (denaturation), 56 C for 15s (annealing) and
72 C for 15s (extension).
Northern blotting
Equal amounts of total RNA from cells with or without
OGD were separated with 0.7% agarose gel and then
transfected onto a membrane. After UV cross-linking,
the membrane was incubated with the probes, biotin-50-
AAAGGTGAAGTTCGTCGTCCAAC-30 (Renilla) and
biotin-50-GAGCACGGAAAGACGATG-30 (Fireﬂy) for
16h. After three washes to remove any free probe, im-
munoblotting was performed using anti-streptoavidin
antibodies.
Polysomal fractionation
Cultured cells were treated with 100mg/ml cycloheximide
5min prior to harvest. They were lysed in polysome lysis
buffer containing 100mM KCl, 5mM MgCl2,1 0 m M
HEPES, 1% Triton X-100, 0.5% sodium deoxycholate
100U/ml RNasin, 100mg/ml of cycloheximide
(Calbiochem) and standard protease inhibitors for 2min
on ice. The total RNA in the samples was determined by
measuring the optical density at 260nm (OD260) and
equivalent amounts of RNA were loaded onto a 30%
(wt/vol) sucrose solution in polysome lysis buffer contain-
ing 500mM KCl and 20 U/ml RNasin without detergents.
Samples were centrifuged at 180000g (for the average
radius of the rotor) for 105min at 4 C in a Sorvall
SW41Ti rotor (Newtown, CT, USA). Fractions of equal
volume were collected from the top. RNA in each fraction
was extracted using TRI reagent (Invitrogen).
Determination of infarct volume and oedema ratio
After 96h of MCA occlusion, rats were deeply
anaesthetized and decapitated and the brain was cut into
2-mm thick coronal block slices. The brain slices were
immersed in 1% solution of 2,3,5-triphenyltetrazolium
chloride (TTC) solution in normal saline at 37 C for
30min and then ﬁxed in 4% paraformaldehyde at 4 C.
Brain oedema (brain swelling) was quantiﬁed by the
ratio of the weight (dry/wet) of the hemisphere. The hemi-
spheres were separated and weighed immediately after
removal and again after drying in an oven at 105 C for
24h.
Statistical analysis
All data from three separate experiments are expressed as
mean±SD. Comparisons among multiple groups were
performed using one-way analysis of variance (ANOVA)
with appropriate post hoc tests, whereas comparisons
between two groups were made using Student’s t-test
(StatView 5.01; SAS Institute). Values of P<0.05 were
considered statistically signiﬁcant.
RESULTS
Focal cerebral ischaemia and OGD induce time-dependent
expression of Sp1: in vivo and in vitro studies
Rats were subjected to the MCAO procedure, and the
success of which was veriﬁed using behavioural outcomes
and Nissl staining for conﬁrmation of hypoxic conditions
(Supplementary Figure S1 and Supplementary Videos S1
and S2). Tissues from ischaemic rats were ﬁxed and
double-labelled with antibodies against Sp1 and NeuN
to examine Sp1 expression in neurons. As illustrated in
Figure 1A, Sp1 expression increased after MCAO in the
ipsilateral hemispheric neurons but remained unaltered in
the contralateral hemisphere. Primary cortical neurons
were subjected to OGD in an in vitro ischaemic model.
Figure 1B shows that total Sp1 levels (phospho-Sp1 and
Sp1) accumulated in primary neurons within 48h of OGD
(ANOVA: F6,14=13.57, P<0.0001). In post hoc analysis,
Sp1 expression levels were signiﬁcantly greater in the
OGD group at 2, 4, 8, 12, 24 and 48h compared with
the naı¨ve control group (P<0.01). These data demon-
strate an increase in Sp1 expression from the early
period of ischaemia both in vivo and in vitro. OGD treat-
ment did not alter the expression of Sp1 in glial cells
(F4,10=0.182, P>0.05; Figure 1C), U87 glioma cells
or A549 lung cancer cells (F4,10=0.2048, P>0.05;
Supplementary Figure S3) indicating that the OGD-
induced up-regulation of Sp1 expression was restricted
to neurons.
H2O2-induced Sp1 expression
An earlier report indicated that Sp1 is induced by oxida-
tion and that Sp1 is an anti-death transcription factor in
5414 Nucleic Acids Research, 2011,Vol.39, No. 13cortical neurons (16). We examined here whether free
radicals or ROS regulate Sp1 expression after OGD treat-
ment. First, we determined whether OGD could induce
H2O2 in primary neurons. As shown in Figure 2A, the con-
centration of H2O2 increased at 0.5h after OGD. ANOVA
showed a main effect of the group (F15,32=42.51,
P<0.0001). Post hoc analysis revealed that at 0.5h the
expression level was signiﬁcantly greater in the OGD
group than in the naı¨ve control group (P<0.01).
Primary neurons that were treated with the NADPH
oxidase inhibitor apocynin harboured lower levels of
H2O2 0.5h after OGD as compared to treatment with
OGD alone (Figure 2A). Pre-treatment with the super-
oxide dismutase mimetic tempol increased H2O2 levels.
In Newman–Keuls post hoc comparison, the naı¨ve
control group differed from neurons that were treated
with tempol 1h before OGD at 0 (P<0.05), 0.5
(P<0.01), 1 (P<0.01) and 1.5h (P<0.01). Notably,
apocynin treatment blocked the OGD-induced increase
in Sp1, and tempol treatment led to higher Sp1 levels
(F3,8=53.11, P<0.0001; Figure 2B). In Newman–Keuls
post hoc comparison, we also observed differences between
the naı¨ve control, OGD and OGD plus tempol groups
(P<0.05). The naı¨ve control and OGD plus apocynin
groups did not differ (P>0.05). Furthermore, we admin-
istered H2O2 directly to neuronal cultures and found that
it signiﬁcantly increased Sp1 expression (F4,10=89.24,
P<0.0001; Figure 2C), and in Newman–Keuls post hoc
comparison, we found differences between the naı¨ve
control and the 1-, 1.5- and 2-h time points (P<0.01).
No signiﬁcant difference was observed between the naı¨ve
control and the 0.5-h time point (P>0.05). Collectively,
these results suggest that OGD-induced Sp1 expression
involves H2O2. Notably, the OGD-induced rise in H2O2
was transient, peaking at 0.5h and stabilizing thereafter
(Figure 2A).
H2O2 and OGD increase Sp1 translational efﬁciency
at the early stage and Sp1 transcriptional activity at
the late period
We performed RT–PCR to measure Sp1 mRNA levels in
primary neurons to determine the mechanism by which
OGD up-regulates Sp1 expression. Total mRNA was ex-
tracted from cultured cortical neurons at various time
points following OGD treatment. Results revealed that
Sp1 mRNA increased after OGD treatment for 8 and
12h (P<0.01; Figure 3A). ANOVA showed a main
effect of the group (F4,11=32.04, P<0.0001), and by
Newman–Keuls post hoc comparison, we observed differ-
ences between the naı¨ve control and the 8- and 12-h
(P<0.01) time points. Next, we investigated whether
Sp1 protein synthesis increased after OGD treatment.
After adding
35S-methionine to the culture medium, we
observed that the expression of
35S-methionine-labelled
Sp1 expression was signiﬁcantly up-regulated following
OGD treatment (F4,10=47.08, P<0.0001; Figure 3B).
Results revealed signiﬁcant differences between the naı¨ve
control and treated groups at the 2, 3 and 4h (P<0.01)
Figure 1. Hypoxia/ischaemia-induced Sp1. (A) Double immunostaining of Sp1 and NeuN at various time points of recovery from MCAO was
performed. Brain sections were obtained at various time points after MCAO and were subsequently probed with anti-Sp1 and anti-NeuN antibodies.
HIF-1a was detected using Alexa 488 (green) while NeuN was detected using Alexa 568 (red). Panels show images taken from the cortex of
non-ischemic and ischemic hemispheres. Scale bar, 50mm. (B and C) The time course of Sp1 expression induced by OGD treatment in primary
neurons or glial cells was assessed. Total lysates of primary neurons (B) or glial cells (C) were obtained at various time points following OGD
challenge. Sp1 expression was detected by performing immunoblotting with anti-Sp1 antibodies using tubulin as an internal control. All experiments
were independently carried out in triplicate and were expressed as a percentage of the levels in the naı¨ve controls. Statistical analysis was carried out
using the one-way ANOVA with appropriate post hoc tests. **P<0.01 versus the naı¨ve control group.
Nucleic Acids Research, 2011,Vol.39, No. 13 5415time points. No signiﬁcant differences were observed
between the naı¨ve control and the 1h groups (P>0.05).
We also examined protein stability during OGD-induced
Sp1 expression by incubating OGD-treated primary
neurons and controls with cycloheximide. Cell lysates
were prepared and analysed at various time points after
cycloheximide treatment. The Sp1 degradation did not
differ signiﬁcantly between OGD-treated neurons and con-
trols (Figure 3C and D). Finally, primary neurons were
pretreated with actinomycin D before OGD treatment to
inhibit transcriptional activity. As shown in Figure 3E,
Sp1 remained up-regulated at 2h in the OGD-treated
neurons even in the presence of actinomycin D; at 8h,
however, this increase vanished (P>0.05). These results
suggest that the up-regulation of Sp1 at the 2h after OGD
correlates with enhanced translation of existing Sp1
mRNAs, whereas OGD-induced Sp1 increases in Sp1 at
later time points (i.e. 8h) are under transcriptional
control.
Although the rise in H2O2 after OGD peaked at 0.5h
(Figure 2A), the Sp1 levels peaked at 2h and plateaued
thereafter (Figure 1B). Thus, Sp1 from H2O2-induced
early spike might bind to the Sp1 promoter to stimulate
transcription of Sp1. This model is indirectly supported by
the ﬁnding that apocynin also blocks Sp1 levels at late
time points by preventing H2O2 formation (Figure 2B).
Thus, to conﬁrm that binding of Sp1 to the Sp1
promoter stimulated its transcription, the Sp1 promoter
was inserted into a pGL3 plasmid that contained the
luciferase gene and was examined for luciferase activity
under OGD conditions. As shown in Figure 3F, Sp1 tran-
scription was induced in the late stage of OGD (P<0.01;
Student’s t-test). Thus, during early ischaemic insult, Sp1
induction may be attributed to increased translational
activity, whereas late Sp1 accumulation may be primarily
due to increased transcriptional activity. To conﬁrm that
Sp1 can auto-regulate its own promoter activity in neuron
cells, Sp1 was expressed by adeno-GFP-Sp1 infection in
neuron primary cells, and the promoter activity of Sp1
was studied (Figure 3F, panel b). The data obtained
indicated that Sp1 promoter-driven luciferase activity in-
creased signiﬁcantly upon Sp1 overexpression. Further,
these results suggest that ROS inﬂuence the Sp1
up-regulation during early ischaemic insult.
Increased ribosome recruitment in a cap-independent
manner and the IRES pathway contributes to
H2O2-induced increases in Sp1 translational efﬁciency
Because Sp1 expression increases within 2h of OGD, the
Sp1 50-UTR might contain an IRES. The IRES Omnibus
WebServer was used to predict the location of a conserved
250-bp IRES motif upstream of the Sp1 coding region.
A typical IRES that forms a Y-shift IRES motif
(Supplementary Figure S4) was identiﬁed in this region.
However, because the transcriptional initiation site (+1)
and the 50-UTR of rat Sp1 mRNA have not been fully
determined, we speculate that a longer 250-bp 50-UTR
might exist in the 50 region of rat Sp1 mRNA. To test
this possibility, several primers were designed and RT–
PCR was performed to estimate the 50-UTR length. As
shown in Figure 4A, a longer 50-UTR (>510bp but
<530bp) was thus identiﬁed (Figure 4A). Based on this
data, we can prove that this IRES motif, the 1st–250th bp
from the translational initiation codon, is really located
Figure 2. Role of H2O2 in Sp1 expression. (A) Primary neurons treated
with either normoxia, OGD, OGD with apocynin or OGD with
tempol. Total lysates were prepared at the 0.5-, 1- and 1.5-h time
points after the recovery from OGD. The concentration of H2O2 was
measured as described in Materials and Methods. (B) Cultured cortical
neurons were pre-treated with either apocynin or tempol 1h prior to
OGD treatment. Further, the cells were harvested 4h after treatment,
immunoblotting was performed with anti-Sp1 antibodies and tubulin
was used as an internal control. The Sp1 expression level was quantiﬁed
in three independent experiments. (C) Total lysates of the primary
neurons were obtained at various time points following H2O2 treat-
ment. Sp1 expression was detected by western blotting using anti-Sp1
antibodies and using tubulin as an internal control. The values repre-
sent the mean±SD. In (B and C), statistical analysis was carried out
using the one-way ANOVA with appropriate post hoc tests. *P<0.05,
**P<0.01 versus the naı¨ve control group.
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whether the predicted IRES could increase Sp1 mRNA
translational efﬁciency, the Sp1 50-UTR containing the
IRES was inserted into a bicistronic reporter plasmid
that harboured Renilla luciferase and ﬁreﬂy luciferase
genes. The resulting construct (pRsp1F) was used to de-
termine the effect of the predicted IRES on ﬁreﬂy lucife-
rase expression by transient transfection into cultured
cortical neurons. As shown in Figure 4B and C, the Sp1
50-UTR increased the ﬁreﬂy luciferase–Renilla luciferase
ratio by 10-fold and 30-fold without or with OGD or
H2O2 treatment in primary neurons, suggesting that
the Sp1 50-UTR uses the IRES to promote translation
(Figure 4B and C, panel a). In addition, to rule out the
possibility that this region of the 50-UTR may contain the
promoter activity, two internal controls were used to
prove the conclusion shown here. First, we constructed a
pRsp1F-promoterless plasmid which deleted the SV40
promoter and to study the luciferase activity of Renilla
and ﬁreﬂy (Figure 4B and C, panel b). The luciferase
activity of Renilla and ﬁreﬂy were nearly abolished.
Second, the ratio of Renilla and ﬁreﬂy luciferase activity
Figure 3. Mechanism underlying the induction of Sp1 expression by OGD challenge. (A) Primary neurons were exposed to OGD challenge and total
RNA was isolated at various time points after the treatment. The mRNA expression of Sp1 was analyzed by RT–PCR. The results are expressed as
arbitrary mRNA units and have been normalized to GAPDH expression. (B) At various time points following OGD treatment, the neurons were
incubated with a medium containing
35S-methionine for 1h. Whole-cell lysates were analysed by immunoprecipitation with anti-Sp1 antibodies
followed by autoradiography. (C) Primary neurons were treated with cycloheximide (100mM) in the absence or presence of OGD treatment. The
samples were analysed by immunoblotting with anti-Sp1 antibodies using tubulin as an internal control. (D) The level of Sp1 was plotted on
logarithmic scales and lines of best ﬁt were calculated for cycloheximide-treated (shaded bar) and cycloheximide plus OGD-treated (open bar) cells.
Error bars show SD. (E) Primary neurons were treated with actinomycin D (1mg/ml) in the absence or presence of OGD treatment. The samples were
analysed by immunoblotting with anti-Sp1 antibodies using tubulin as an internal control. (F) Sp1 promoter was inserted into pGL3 containing the
luciferase gene, and then transfected into primary cells with or without OGD and adeno-GFP-Sp1 virus infection for 24h to determine luciferase
activity. Statistical analysis was carried out using Student’s t-test. *P<0.05 versus the naı¨ve control group. In (A, B, D and E), all experiments were
carried out independently in triplicate and were expressed as a percentage of the levels in the naı¨ve controls. Statistical analysis was carried out using
the one-way ANOVA with appropriate post hoc tests. *P<0.05, **P<0.01 versus the naı¨ve control group.
Nucleic Acids Research, 2011,Vol.39, No. 13 5417Figure 4. The Sp1 50-UTR contains an IRES. (A) Primers were designed in the different regions of the Sp1 gene including the coding and
non-coding region. Total RNA was extracted for preparing the cDNA, which was used as a template for PCR. PCR products were analysed by
gel and then inserted into the biscistronic plasmid between the Renilla luciferase gene and ﬁreﬂy luciferase gene. (B and C) Primary neurons were
transiently transfected with pRsp1F or pRF (panel a) and pGL2-RF or pGL2-Rsp1F (panel b). Thirty hours post-transfection, the cells were
(continued)
5418 Nucleic Acids Research, 2011,Vol.39, No. 13was studied under OGD or H2O2 treatment (Figure 4B
and C, panel c). Data indicated that there was no signiﬁ-
cant variation between Renilla and ﬁreﬂy luciferase activ-
ity. These data imply that the 50-UTR of Sp1 inserted in
the bicistronic plasmid has no promoter activity. To verify
that the increased ﬁreﬂy luciferase codons were not
translated, but due to the re-initiation of ribosomes that
failed to dissociate from the mRNA after encountering the
stop codon of the upstream Renilla luciferase, a palin-
dromic sequence was inserted into the transcriptional
start site to form a strong stem–loop structure adjacent
to the 50-cap, which inhibits cap-dependent translation
(30). Compared with the pRF group, relative ﬁreﬂy
luciferase activity increased signiﬁcantly in the
pStemRSp1F and pRSp1F groups (Figure 4D), indicating
that the translation of the ﬁreﬂy luciferase does not need
the 50-cap on Renilla mRNA. Conversely, IRES activities
are modulated by proteins called IRES trans-activating
factors (ITAFs) (31,32). We used the mRNA of the trans-
fected plasmids, pRF and pRsp1F, to perform RNase pro-
tection assay, and then detected the region between Renilla
and ﬁreﬂy luciferase mRNA by RT-PCR assay to deter-
mine whether this IRES region is protected during OGD
treatment. As shown in Figure 4E, a Northern blot assay
using ﬁreﬂy luciferase-coding sequence (634th–656th bp)
and Renilla luciferase-coding sequence (1462th–1479th bp)
labelled with biotin as a probe was carried out to detect
the bicistronic mRNA (Figure 4E, panel a). Data
indicated that only full-length bicistronic mRNA contain-
ing the Renilla and ﬁreﬂy luciferase mRNA was observed,
not individual Renilla or ﬁreﬂy luciferase mRNA (Figure
4E, panel a). The total RF and Rsp1F mRNA expression
did not alter after 2h of OGD treatment, but nearly all of
the RF mRNA was abolished upon RNAse treatment
with or without OGD. However, more Rsp1F mRNA
shielded from RNAse degradation under OGD condition
indicates that the IRES motif forms a Y-shift against
RNAse activity (F3,8=177.4, P<0.0001) (Figure 4E,
panel b). These results suggest that the Sp1 50-UTR
indeed contains a conserved sequence that promotes trans-
lational efﬁciency through a cap-independent pathway
(i.e. the IRES pathway) and that the Sp1 IRES is activated
by ROS speciﬁcally H2O2.
To determine whether Sp1 translational efﬁciency is
altered after OGD or H2O2 treatment, we examined the
effects of OGD and H2O2 on Sp1 mRNA distribution on
polysomes. We used a linear 30% sucrose solution con-
taining 500mM KCl to prevent any non-translational
interactions between mRNAs and ribosomes. Under
normoxic conditions, distribution of Sp1 mRNA on poly-
somes showed a peak in fraction 12 (Figures 5A–C). OGD
led to a selective increase in the number of ribosomes that
were associated with Sp1 transcripts, distributing them to
the larger polysome fractions 14 and 15 (Figure 5A, panel
a). In contrast, glyceraldehydes-3-phosphate dehydrogen-
ase (GAPDH) mRNA remained primarily in polysome
fractions 12 and 13 during normoxia and OGD (Figure
5A, panel b). Treatment with apocynin suppressed the
OGD-induced shift in the distribution of Sp1 transcripts
to a larger polysome fraction (Figure 5A, panel a) but had
a minimal effect on the distribution of GAPDH tran-
scripts after OGD (Figure 5A, panel b). Moreover,
H2O2 led to an increase in the number of ribosomes that
were associated with Sp1 mRNA, distributing them to
polysome fractions, 14, 15 and 16 (Figure 5B, panel a)
but did not affect the ribosome distribution on GAPDH
mRNA (Figure 5B, panel b). Notably, the same effect was
observed when ribosomes and Sp1 mRNAs from the
brains of MCAO rats were assayed in the same manner.
MCAO rats showed an increase in the number of ribo-
somes that were associated with Sp1 mRNA with more
polysomes present in fractions 15, 16 and 17 (Figure 5C,
panel a), whereas no such changes were seen for GAPDH
mRNA (Figure 5C, panel b). Thus, these results indicate
that in vitro OGD and in vivo MCAO raise intracellular
ROS concentrations, especially that of H2O2, thus stim-
ulating Sp1 translational efﬁciency of Sp1 through the
IRES-dependent pathway to increase Sp1.
Protective effect of Sp1 following OGD- or
MCAO-induced brain damage
The potential neuroprotective effects of Sp1 were exam-
ined in vitro using primary cortical neurons and in vivo
using the MCAO stroke model in rats by blocking Sp1
binding to DNA with mithramycin A or WP631.
Further, the Sp1 short hairpin RNA (shRNA) was used
to knock-down Sp1 in primary neurons to examine Sp1
function in neuronal survival. As shown in Figure 6A and
B, 24-h OGD in primary cortical neurons reduced
Figure 4. Continued
subjected to OGD (B) or H2O2 (C). The value of ﬁreﬂy luciferase activity was divided by that of Renilla luciferase activity and was then ﬁnally
normalized with that of the pRF only. Real RLU values are shown here. The mRNA levels of ﬁreﬂy luciferase and Renilla luciferase were measured
by performing real-time RT–PCR and served as the internal control (B and C, panel c). Statistical signiﬁcance of the difference between the normoxic
and treatment groups was tested using the one-way ANOVA with appropriate post hoc tests. *P<0.05, **P<0.01 versus the pRF in the normoxia
group. (D) Effect of a 50 stem–loop on relative expression of the downstream reporter enzyme. Primary neurons were transfected with pRF, pRsp1F
or pStemRsp1F. Thirty hours post-transfection, cells were harvested to detect the luciferase activity, and then the IRES activities are representeda s
ratios of ﬁreﬂy luciferase to Renilla luciferase. The ratios are graphed relative to the ratio obtained with pRF, which was given a value of 1. The data
shown are mean (±SEM) of triplicate samples from each of three independent experiments. (E) pRF or pRsp1F were transfected into primary
neurons for 12h, and then were subjected to OGD or were left under control conditions for 2h before harvesting. Total RNA was extracted and
separated with 0.7% gel in a northern blot assay by using the ﬁreﬂy luciferase-coding sequence (1462th–1479th bp) and renilla luciferase-coding
sequence (634–656th bp) labelled with biotin as a probe. Finally, the streptavidin and anti-streptavidin were used to ﬁnd the mRNA signal (panel a).
Total lysates of primary neurons were then incubated with RNase (10mg/ml) at 0 C and the remaining 50-UTR of the Sp1 IRES region in each
group, and the RF mRNA and Rsp1F mRNA was measured by real-time RT–PCR (panel b). These levels were expressed as a percentage of those of
the naive controls. Statistical analysis was performed using one-way ANOVA with appropriate post hoc tests. *P<0.05, **P<0.01 versus the naive
control group.
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cell viability did not decrease signiﬁcantly compared with
OGD treatment alone; indicating that Sp1 induction
during OGD protects cells. Next, we examined whether
endogenous Sp1 confers protection against MCAO-
induced brain injury by injecting mithramycin A into the
injured regions of ischaemic brains 0.5h after MCAO.
Brain oedema, as indicated by increased brain/water
content, was typically observed 48h after the MCAO
procedure. The water content in the MCAO ipsilateral
hemispheres increased signiﬁcantly compared with the
sham-control group (F7,16=20.48, P<0.0001; Figure
6C). Mithramycin A administered 0.5h after MCAO
further increased the mean water content of the ipsilateral
hemispheres relative to those in the MCAO group. Brain
water content in the contralateral hemispheres did not
differ between the MCAO and MCAO-mithramycin A
groups (Figure 6C). Furthermore, we measured the extent
of damage 4 days after MCAO using 2,3,5-triphenyl tetra-
zolium chloride. Cerebral infarction in the rat brains of
each group is shown in Figure 6D. The white areas
indicate infarction. Severe infarction was observed in all
of the MCAO rats. Administration of mithramycin A
0.5h after MCAO signiﬁcantly increased infarct volume
compared to treatment with MCAO alone (Figure 6D).
Conversely, in immunohistochemistry using anti-NeuN
antibodies, administration of mithramycin A, 0.5h after
MCAO decreased the number of NeuN-positive neurons
in ipsilateral hemispheres compared to treatment with
MCAO alone (Figure 6E).
Finally, on TUNEL staining of Sp1 knock-down pri-
mary neurons, the number of apoptotic cells was higher in
the Sp1 shRNA plus OGD group than in the OGD group
(Figure 7A). In addition, Sp1 knock-down by shRNA
attenuated cell viability compared with OGD treatment
alone (Figure 7B). Differences in cell viability were
observed between the naı¨ve control, OGD, OGD plus
Sp1 shRNA and the OGD plus luciferase shRNA
groups (control shRNA) (Figure 7B). However, under
conditions in which OGD was not induced, cell viability
did not differ between the control, Sp1 shRNA and
luciferase shRNA groups (P>0.05). Thus, Sp1 apparently
regulates cell survival only under hypoxic/ischaemic
conditions.
DISCUSSION
This study described novel ﬁndings addressing several im-
portant issues with regard to neuronal survival. The early
rise in H2O2 during OGD/ischaemic insult might be used
by neurons as a signalling mechanism to elicit endogenous
neuroprotective activity in neurons. The 50-UTR of Sp1 is
Figure 5. Ribosomal distribution with respect to Sp1 mRNA during OGD or H2O2 treatment. (A) Panel a shows the effect of normoxia, OGD and
OGD with apocynin on the polysomes distribution in cultured cortical neurons with respect to Sp1 mRNAs. GAPDH mRNA served as an internal
control (A panel b). (B) Panel a shows the effect of H2O2 in cultured cortical neurons on polysomes distribution with respect to Sp1 mRNA, with
GAPDH mRNA serving as an internal control (B, panel b). (C) Panel a shows the effect of MCAO in rats on polysomes distribution with respect to
Sp1 mRNA and GAPDH mRNA was used as an internal control (C, panel b). RNA in each fraction was extracted and the product of RT–PCR was
presented. The results are shown as a percentage of the speciﬁc mRNA in each fraction, where the total amount of the speciﬁc mRNA in all fractions
was set at 100%. The data shown are mean (±SEM) of triplicate samples from each of three independent experiments.
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activate the Sp1 IRES in neurons and increase Sp1 trans-
lation. Ischemia-activated Sp1 is neuroprotective. Finally,
the early rise in Sp1 auto-activates the Sp1 promoter in a
forward manner increasing late transcription of Sp1
(Figure 7C).
As a ROS, H2O2 is recognized as a pro-death molecule,
because it reacts with superoxide anion to form hydroxyl
radicals or reacts with nitric oxide to form peroxynitrate.
Several reports have indicated that H2O2 is neuropro-
tective (16), however, our in vitro and in vivo results
suggest that H2O2 is used by neurons as a signalling
molecule to trigger endogenous neuroprotective mechan-
isms. We observed that neurons respond to H2O2 and use
it to activate the IRES region of Sp1 to mediate a relative-
ly early and rapid rise in Sp1 through cap-independent
translation. However, it is still not clear why H2O2 acti-
vates Sp1 translation only in neurons and not in glial cells.
Perhaps neurons and glial cells have disparate ITAFs that
respond differently to H2O2, but more experiments are
needed to conﬁrm this hypothesis. Regarding the Sp1
IRES, speciﬁcally the 50-UTR of Sp1, although much is
known about this important transcription factor, the exact
length of its 50-UTR has not been really established. To
this end, we identiﬁed a much longer 50-UTR of Sp1 and
discovered that it contains an IRES region, conﬁrming our
hypothesis that H2O2 activates Sp1 translation through a
fast mechanism (i.e. via the IRES system rather than the
Figure 6. Effects of Sp1 inhibitors on brain injury after hypoxia/ischaemia challenge. (A and B) Primary neurons were treated with mithramycin A
(A) or WP631 (B), followed by OGD treatment. Viability of the cultured cortical neurons was assessed by MTS assay in which Sp1 expression level
was used as an internal control. Experiments were carried out independently in triplicate. The values that were normalized to the protein content are
provided as the mean±SD (n=3) and are expressed as percent viability relative to untreated cells. Statistical analysis was carried out using one-way
ANOVA with appropriate post hoc tests. *P<0.05 versus the naı¨ve control group; yP<0.01 versus the OGD group. (C) Hemispheres were separated
and weighed immediately after removal and again after drying in an oven at 105 C for 24h. Data are presented as mean±SD (n=4). (D) Infarct
area was evaluated by TTC staining. Representative sections from the indicated treatments after 4day of recovery are shown. (E) Brain sections were
obtained 4day after MCAO recovery, probed with anti-NeuN antibodies and detected with Alexa 568 (red). The nucleus was stained with 40,
6-diamidino-2-phenylindole (DAPI; blue). Scale bar, 50mm. Statistical analysis was carried out using one-way ANOVA with appropriate post hoc
tests. *P<0.05 versus the sham-control group.
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neurons, enabling them to respond quickly to ischaemic
attack.
Sp1 is known to be pro-apoptotic and pro-survival, and
the neuronal injury-inducible gene is synergistically
regulated by ATF3, c-Jun and STAT3 through the inter-
action with Sp1 in damaged neurons but the detailed
function of Sp1 in ischaemic insult or stroke is less well
understood (20,21). Using both inhibitors that block Sp1
binding to DNA and using shRNAs against Sp1, we
demonstrated that Sp1 is neuroprotective both in vitro
and in vivo. As discussed, the early rise in H2O2 induces
an increase in Sp1 through a fast translational system
involving the IRES. In this regard, we observed that the
upstream promoter of Sp1 contains a G/C-rich region that
serves as an Sp1-binding motif to enhance Sp1 transcrip-
tion. Based on our data, we propose a model in which
H2O2 causes an early rise in Sp1 that auto-activates the
Sp1 promoter in a forward manner, causing a subsequent
rise in Sp1 during the course of ischaemic insult. We
speculate that the rises in Sp1 during the early or late
phases protect neurons against ischaemia-induced
injuries. Based on a bioinformatics screen of gene expres-
sion under hypoxic conditions (GEO accession no.
GSE63), it is notable that most genes activating during
hypoxic conditions are regulated by Sp1 and are related
to cell survival (Supplementary Figure S2). In contrast,
other genes such as cyclooxygenase-2 and caveolin-1 (33)
are also activated by Sp1 and regulate the pathology of
neurodegenerative diseases, including Huntington and
Alzheimer disease (34–36). Exactly which genes are
activated by Sp1 and how they are related to neuronal
survival requires further investigation.
In conclusion, we have observed several novel ﬁndings
and have shown that the ROS H2O2 plays a critical pro-
survival role in neurons during ischaemic insult by rapidly
causing an early rise in the transcription factor Sp1
through an IRES-dependent translational mechanism.
Thus, agents that increase H2O2 such as tempol or other
agents that artiﬁcially activate the IRES system may con-
stitute new, effective therapeutic interventions against
ischaemic insult and stroke.
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Figure 7. Effect of shRNA targeting Sp1 on cellular apoptosis after ischaemic challenge. (A) shRNA targeting Sp1 or luciferase was transfected into
primary cortical neurons 30h before OGD. TUNEL staining was performed 96h after OGD challenge. A TUNEL-positive cell counting analysis was
determined under each condition. Scale bars, 50mm. (B) Sp1 levels in OGD-treated or OGD-untreated primary neurons were knocked-down by
Sp1-shRNA. Viability of the cultured cortical neurons was assessed by the MTS assay, for which Sp1 expression levels were used as an internal
control. All experiments were carried out independently in triplicate. The values that were normalized to the protein content are provided as
mean±SD (n=3) and are expressed as percent viability relative to the untreated cells. Statistical analysis was carried out using the one-way
ANOVA with appropriate post hoc tests. *P<0.05 versus the naı¨ve control group; yP<0.05 versus OGD plus luciferase shRNA group. (C) The
model proposed here was used to elucidate the accumulation of Sp1 and its role under ischaemic conditions.
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